Pearl Lui
Family Medicine · Brooklyn, NYNPI 1558723353
Payments from drug & device makers
Across 128 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$313
- GSK$297
- Lilly USA, LLC$272
- Bausch Health US, LLC$233
- Gilead$208
- Viiv Healthcare Company$126
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,843100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $313 |
| GSK | 14 | $297 |
| Lilly USA, LLC | 12 | $272 |
| Bausch Health US, LLC | 9 | $233 |
| Gilead | 9 | $208 |
| Viiv Healthcare Company | 4 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Exact Sciences | 4 | $105 |
| Dynavax Technologies Corporation | 4 | $93 |
| Phadia US Inc. | 5 | $88 |
| AbbVie | 3 | $82 |
| Pfizer | 4 | $80 |
| Hologic Sales And Service, LLC | 3 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Organon | 3 | $71 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Evofem Biosciences, Inc. | 3 | $51 |
| Corium, LLC | 2 | $50 |
| Merck | 3 | $43 |
| Amgen | 2 | $42 |
| Boston Scientific | 1 | $39 |
| Tris Pharma Inc | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $38 |
| VBI Vaccine (delaware) Inc. | 1 | $37 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Bayer | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| Abbott | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $20 |
| Alk-abello, Inc | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,843 in reported general payments places this provider in the 80th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $141 |
| Atorvastatin Calcium | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brooklyn
- Michael YuryevBrooklyn$589K
- Matthew SpitzerBrooklyn$469K
- Walford LindoBrooklyn$104K
- Fu Fu HeBrooklyn$101K
- Jonathan ChangBrooklyn$66K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.